Foracort 100 Dosing for 10-Year-Old Child with Asthma
For a 10-year-old child (24 kg) with asthma, Foracort 100 (budesonide 100 µg/formoterol 6 µg) should be dosed as 2 inhalations twice daily (total daily dose: budesonide 400 µg/formoterol 24 µg), which provides appropriate controller therapy for this age group based on current guidelines and pediatric evidence 1, 2.
Dosing Rationale
The 2020 NAEPP guidelines establish that children aged 5-11 years with persistent asthma requiring step-up therapy should receive inhaled corticosteroid (ICS) plus long-acting beta-agonist (LABA) combinations 1. The evidence specifically supports:
Standard maintenance dosing: Budesonide/formoterol 160/9 µg (delivered as 2 inhalations of 80/4.5 µg) twice daily demonstrated statistically significant and clinically meaningful lung function improvements versus budesonide alone in children 6 to <12 years 2.
Lower dose considerations: The 160/4.5 µg twice daily dose (equivalent to your Foracort 100 formulation at 2 inhalations) did not show statistical superiority over budesonide alone in the primary endpoint, though it remained safe and effective 2.
Practical Application
Given that Foracort 100 contains budesonide 100 µg/formoterol 6 µg per inhalation:
- Recommended regimen: 2 inhalations twice daily = 200 µg budesonide/12 µg formoterol per dose
- Total daily dose: 400 µg budesonide/24 µg formoterol
- This approximates the studied 160/9 µg twice daily regimen that showed efficacy in pediatric trials 2, 3
Important Caveats
Device technique is critical: Children aged 10 years can typically use a pressurized metered-dose inhaler (pMDI) effectively, but proper spacer use and technique verification are essential. Studies demonstrating efficacy used proper inhalation technique 3, 4.
Monitoring requirements:
- Assess control every 2-6 weeks initially 1
- Check adherence and inhaler technique at each visit
- Consider stepping down only after 3 consecutive months of good control 1
- Growth monitoring is important; pediatric studies showed acceptable growth patterns with budesonide/formoterol 5
Safety Profile
The combination is well-tolerated in this age group. Pediatric safety data from multiple trials showed:
- No serious adverse events related to treatment 2, 3
- Similar adverse event profiles to budesonide alone 3
- The FDA label confirms safety in children ≥5 years, though it emphasizes that LABAs should be used with ICS in fixed combination to ensure adherence 6
Critical warning: The FDA issued guidance that LABAs increase risk of asthma-related hospitalization when used without ICS in pediatric patients. Fixed-dose combinations like Foracort ensure both medications are taken together 6.
Alternative Considerations
If asthma remains uncontrolled on this regimen, the 2020 guidelines support stepping up to higher-dose ICS-LABA or adding leukotriene receptor antagonists 1. Conversely, if well-controlled for ≥3 months, consider stepping down to lower doses or ICS monotherapy 1.
The evidence strongly supports budesonide/formoterol combinations in children 6-11 years, with the 160/9 µg twice daily dose showing the most robust efficacy data 2. Your Foracort 100 formulation at 2 inhalations twice daily provides comparable dosing and represents appropriate therapy for this 10-year-old patient.